Buy now 9 900 €
ref : 13493
Year of mfg. : 2018
Available on 2026-08-15
Latest check up : 2026
Possible installation on quotation
Used equipment inspected by our experts
Functional condition: very good
Cosmetic condition: very good
Avedro reliability and precision
Express shipping available upon request
The CE-marked KXL® system has a sleek, mobile design with a large touchscreen and wireless remote control that makes it easier to use. Together with 4 preset (changeable) protocols, a fifth user programmable treatment protocol, and the Glaukos family of high-quality riboflavin formulations, you can choose from proven and predictable protocols for your patients via epithelium-off (epi-off), accelerated, pulsed, or continuous treatments.
The KXL® system features:
Up to 45 mW/cm2 of power for effective cross-linking
Wireless remote control for accurate and convenient X, Y, and Z axis adjustments during treatment
Large 25.7 cm touchscreen monitor for premium operator visibility and ease of use
4 preset treatment protocols for safety, efficiency, and accuracy
Fifth user programmable treatment protocol for convenience
Intuitive software user interface
Live camera for ease of alignment and image acquisition
On-board patient database for easy reference and planning
Exportable patient treatment report for record keeping
Procedures performed with the KXL® system include cross-linking and Lasik Xtra®.
There was an error when considering the interest of the product. Please try or contact the support.
Your partnership request has been sent by email to the OPHTAZON team.
Your partnership request has been sent by email to the OPHTAZON team.
Your application for a partnership was not successful. Please try again or contact the support.
HOME
sales@ophtazon.com / +33 141 515 490
INTERNATIONAL SALES MANAGER
M. Sadreddine MEHRI
sadreddine.mehri@ophtazon.com / +33 6 08 84 07 42
TECHNICAL & SALES MANAGER IVORY COAST
M. Khaled SELLAMI
khaled.sellami@ophtazon.com / +225 07 68 46 36 14
Nous utilisons différentes technologies pour optimiser votre expérience utilisateur.
Merci de cliquer sur le bouton pour donner votre accord.
Vous souhaitez en savoir plus ? Cliquez ici